CASP3 and coronary artery disorder: This prompted further investigations on a molecular level that revealed that cleaved caspase-3 p17 peptide, an apoptosis-related cysteine peptidase, is not only elevated among CAD patients experiencing STEMIs, but also present within atherosclerotic plaques (75).